Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationCurrent Price
as of Dec 02, 2024$59.94
P/E Ratio
N/A
Market Cap
$121.57B
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Overview
Trading Information
Company